๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Impact of interferon-alpha therapy on liver fibrosis progression in patients with HBeAg-negative chronic hepatitis B

โœ Scribed by G. V. Papatheodoridis; K. Petraki; E. Cholongitas; E. Kanta; I. Ketikoglou; E. K. Manesis


Book ID
108885748
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
92 KB
Volume
12
Category
Article
ISSN
1352-0504

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Long-term outcomes of thymosin-ฮฑ1 and in
โœ Murat Saruc; Nuri Ozden; Nurten Turkel; Semin Ayhan; Lynette M. Hock; Isil Tuzcu ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 179 KB ๐Ÿ‘ 1 views

Hepatitis B e antibody (HbeAb) and hepatitis B virus (HBV) DNA positive chronic hepatitis is a clinical entity, distinct from classical hepatitis B e antigen (HbeAg) positive chronic hepatitis B. Our aim was to evaluate the long-term therapeutic efficacy of the combination of interferon alpha-2b and